StockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS)

StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a report issued on Monday morning. The firm issued a hold rating on the stock.

Milestone Scientific Stock Performance

Shares of NYSE:MLSS opened at $0.97 on Monday. The firm has a market cap of $74.91 million, a PE ratio of -9.70 and a beta of 1.08. Milestone Scientific has a 52 week low of $0.52 and a 52 week high of $1.10. The firm’s fifty day moving average is $0.97 and its 200-day moving average is $0.78.

Milestone Scientific (NYSE:MLSS) last released its quarterly earnings results on Thursday, August 15th. The company reported ($0.02) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.01). Milestone Scientific had a negative net margin of 54.87% and a negative return on equity of 60.78%. The company had revenue of $1.85 million during the quarter.

Insider Transactions at Milestone Scientific

In other news, Director Leonard Osser sold 141,913 shares of the stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $0.95, for a total transaction of $134,817.35. Following the completion of the sale, the director now directly owns 4,602,506 shares in the company, valued at $4,372,380.70. The transaction was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 24.75% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.